Alzheimer treatment videos (click here to see videos of actual treatment results)
The patented** Tobinick anti-TNF method for treatment of Alzheimer's disease

as seen on the BBC, New Scientist, CNN, Fox News, ABC News, Bloomberg News, Reuters Health, the Times Online (U.K.), the Daily Telegraph(U.K.), UPI, and discussed on Medscape, in a university press release, and in Nature Clinical Practice Neurology
*New: Physician Training Program:click here


The Tobinick Alzheimer Method™ is a unique, pioneering, patented** off-label treatment method for selected patients with Alzheimer's Disease who have failed to adequately respond to conventional medical treatment. The concept of TNF-inhibition for treatment of neurodegenerative disease has recently been reviewed (Tweedie D, Sambamurti K, Greig NH. Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, US. TNF-alpha Inhibition as a Treatment Strategy for Neurodegenerative Disorders: New Drug Candidates and Targets. Curr Alzheimer Res. 2007 Sep;4(4):375-8). The publications and patents of Edward Tobinick MD have been cited by an increasing number of scientific and patent publications from academic and pharmaceutical researchers from around the world.

This unique treatment program is currently open to a limited number of new patients. Appointments for consultation for evaluation can be scheduled by calling the INR at (310) 824-6199, Monday through Friday 9 AM to 5 PM.

*For a more detailed scientific explanation, please see the For physicians and scientists webpage. Videos of family members discussing their observations of the effect of treatment of Alzheimer's utilizing the Tobinick Method™ at the INR can be viewed on the Alzheimer treatment videos webpage. To download a PDF copy of our newly published article reporting the results of treatment utilizing the Tobinick Alzheimer Method™, entitled "Rapid cognitive improvement in Alzheimer's disease..., please click here. The importance of the article was demonstrated by its selection and evaluation on F1000 Biology with an "exceptional" rating, classified as a potential landmark paper representing the top 1% of publications. It was accompanied by an editorial about the Tobinick Method™, also available as a PDF download. The article has now also been selected for discussion in a leading neurology journal, Nature Clinical Practice Neurology.


Institute for Neurological Research, a private medical group, inc.
100 UCLA Medical Plaza, Suites 205-210 Los Angeles, California 90095

Edward Tobinick MD, Director

Appointments and Information: (310) 824-6199

<Map and Directions><Appointments><Terms of Use><Memory Disorders Program-detailed brochure (PDF)><Alzheimer treatment videos><Dementia><Citations to INR publications>
Copyright ©2008, the Institute for Neurological Research® (INR®), a private medical group, inc., all rights reserved. **U.S. patents 6015557, 6177077, 6419934, 6419944, 6471961, 6537549, 6982089, 7214658 and additional issued and pending U.S. and foreign patents. These patents are assigned to TACT IP LLC. Tobinick Alzheimer Method™ and Tobinick Method™ are trademarks of the INR.